Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

China · Delayed Price · Currency is CNY

14.82

+0.04 (0.27%)

Sep 30, 2026, 3:04 PM CST

Market Cap	2.37B -4.9%
Revenue (ttm)	267.01M +1.8%
Net Income	62.02M +9.2%
EPS	0.39 +11.6%
Shares Out	160.00M
PE Ratio	38.02
Forward PE	n/a
Dividend	0.30 (2.02%)
Ex-Dividend Date	May 29, 2026

Volume	2,872,400
Open	14.58
Previous Close	14.78
Day's Range	14.58 - 15.05
52-Week Range	11.53 - 18.25
Beta	0.31
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 26, 2026

About SHE:300519

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers Chinese patent medicines, chemical medicines, and health food in various forms, including tablets, mixtures, granules, syrups, powders, hard capsules, and oral liquids, as well as drinks. Its products are used for the treatment of cardiovascular, trauma, respiratory, digestive, urinary, pediatric, and immunity diseases. The company was incorporated in 1998 and is headquartered ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1998

Employees 309

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300519

Full Company Profile

Financial Performance

In 2025, SHE:300519's revenue was 265.36 million, a decrease of -0.86% compared to the previous year's 267.66 million. Earnings were 54.21 million, an increase of 7.58%.

Financial Statements